{"schema_version":"secwatch.filing_event.v1","accession":"0001384101-25-000010","form_type":"8-K","ticker":"VCYT","cik":"0001384101","company_name":"VERACYTE, INC.","filed_at":"2025-02-24T23:59:59+00:00","discovered_at":"2026-05-14T18:03:03.490918+00:00","generated_at":"2026-05-26T05:39:25.861190+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Veracyte Q4 revenue $118.6M (+21%), net income $5.1M vs. loss a year ago","bullets":["Q4 total revenue $118.6M (+21%), testing revenue $112.2M (+24%), testing volume +25% to 39,107 tests.","Q4 net income $5.1M vs. net loss in Q4 2023; adjusted EBITDA $26.1M (22.0% margin), up 76%.","Full-year 2024 revenue $445.8M (+23%), net income $24.1M vs. 2023 loss; adj. EBITDA $91.9M (20.6%).","Decipher revenue +44% in Q4, volume +45% to >22,400 tests; Afirma revenue +4%, volume +8%.","Cash from operations $75.1M in 2024; ended with $289.4M cash & short-term investments."],"urls":{"canonical":"https://secwatch.observer/filing/0001384101-25-000010","json":"https://secwatch.observer/filing/0001384101-25-000010.json","markdown":"https://secwatch.observer/filing/0001384101-25-000010.md","text":"https://secwatch.observer/filing/0001384101-25-000010.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1384101/000138410125000010/0001384101-25-000010-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1384101/000138410125000010/vcyt-20250224.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-26T05:39:25.861190+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}